Preoperative NSAID to Colorectal Cancer Patients

  • Tell a FriendPrint

The study is designed to evaluate effects of NSAIDs on immune activity inside and close to tumor tissue in patients with colorectal cancer...

Brief Summary

Official Title: “Preoperative Treatment With NSAID in Colorectal Cancer Patients in Relationship to Tumor Host Reactions”

The study is designed to evaluate effects of NSAIDs on immune activity inside and close to tumor tissue in patients with colorectal cancer.

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Detailed Clinical Trial Description

Study and control patients are randomized to receive preoperative treatment with indomethacin or celecoxib compared to sham treatment.Tumor biopsies are taken at operation and used for analyses of tumor immunity and gene expression.

Intervention(s) in this Clinical Trial

  • Drug: Indomethacin, celecoxib, esomeprazole

Outcome Measures for this Clinical Trial

Primary Measures

  • Immune reactivity
    • Time Frame: Acute evaluations

Criteria for Participation in this Clinical Trial

Inclusion Criteria:

  • Colon carcinoma scheduled for curative operation

Exclusion Criteria:

  • Diabetes, steroid medication, liver and kidney impairment

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 40 Years

Maximum Age for this Clinical Trial: 80 Years

Are Healthy Volunteers Accepted for this Clinical Trial?: No

Clinical Trial Investigator Information

Lead Investigator: Göteborg University Other

Overall Clinical Trial Officials and Contacts

Kent Lundholm, MD, prof Principal Investigator Göteborg University  

Additional Information

Information obtained from ClinicalTrials.gov on February 12, 2012

Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00473980

Study ID Number: kl4501122

ClinicalTrials.gov Identifier: NCT00473980

Health Authority: Sweden: The National Board of Health and Welfare

Göteborg University

  • Tell a FriendPrint

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00473980